First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer

Overview of attention for article published in Frontiers in immunology, March 2023

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 2,454 followers.

First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer #lymphoma #lymsm https://t.co/goX1TCWzas

First in man study: Bcl-Xl_42-CAF<sup>®</sup>09b vaccines in patients with locally advanced prostate cancer #lymphoma #lymsm https://t.co/afL43alSlb

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.